TACTICS: TACE Plus Sorafenib Improves PFS in Unresectable HCC ...Middle East

Medscape - News
Combining transcatheter arterial chemoembolization (TACE) therapy with sorafenib improved progression-free survival (PFS), but not overall survival (OS), when compared with TACE alone. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( TACTICS: TACE Plus Sorafenib Improves PFS in Unresectable HCC )

Apple Storegoogle play

Also on site :

Most viewed in News


Latest News